BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11455465)

  • 1. Adjuvant therapies using biliary stenting for malignant biliary obstruction.
    Miura Y; Endo I; Togo S; Sekido H; Misuta K; Fujii Y; Kubota T; Tanaka K; Nagahori K; Shimada H
    J Hepatobiliary Pancreat Surg; 2001; 8(2):113-7. PubMed ID: 11455465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallic stents in malignant biliary obstruction: prospective long-term clinical results.
    Lee BH; Choe DH; Lee JH; Kim KH; Chin SY
    AJR Am J Roentgenol; 1997 Mar; 168(3):741-5. PubMed ID: 9057527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas.
    Maire F; Hammel P; Ponsot P; Aubert A; O'Toole D; Hentic O; Levy P; Ruszniewski P
    Am J Gastroenterol; 2006 Apr; 101(4):735-42. PubMed ID: 16635221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High single-session success rate of endoscopic bilateral stent-in-stent placement with modified large cell Niti-S stents for malignant hilar biliary obstruction.
    Kogure H; Isayama H; Nakai Y; Tsujino T; Matsubara S; Yashima Y; Ito Y; Hamada T; Takahara N; Miyabayashi K; Mizuno S; Mohri D; Kawakubo K; Sasaki T; Yamamoto N; Hirano K; Sasahira N; Tada M; Koike K
    Dig Endosc; 2014 Jan; 26(1):93-9. PubMed ID: 23517109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tannenbaum and metal stents in the palliative treatment of malignant distal bile duct obstruction: a comparative study of patency and cost effectiveness.
    Katsinelos P; Paikos D; Kountouras J; Chatzimavroudis G; Paroutoglou G; Moschos I; Gatopoulou A; Beltsis A; Zavos C; Papaziogas B
    Surg Endosc; 2006 Oct; 20(10):1587-93. PubMed ID: 16897286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Clinical Application of Y-Shaped Jogged Stent Implantation in Patients with Malignant Hilar Biliary Obstruction.
    Zhao Z; Song J; Fan X; Fang S; Chen M; Chen W; Wu F; Zheng L; Tu J; Ji J
    J Gastrointest Surg; 2019 Apr; 23(4):745-750. PubMed ID: 30790219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous placement of metallic stents in the management of malignant biliary obstruction.
    Chiou YY; Tseng HS; Chiang JH; Hwang JI; Chou YH; Chang CY
    J Formos Med Assoc; 2005 Oct; 104(10):738-43. PubMed ID: 16385376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of the Ultraflex Diamond stent for the palliation of malignant biliary obstruction.
    Ahmad J; Siqueira E; Martin J; Slivka A
    Endoscopy; 2002 Oct; 34(10):793-6. PubMed ID: 12244500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes of Bilateral Stent-in-Stent Placement Using Self-Expandable Metallic Stent for High-Grade Malignant Hilar Biliary Obstruction.
    Heo JY; Lee HS; Son JH; Lee SH; Bang S
    Yonsei Med J; 2018 Sep; 59(7):827-833. PubMed ID: 30091315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expandable metal biliary stenting in patients with recurrent premature polyethylene stent occlusion.
    Menon K; Romagnuolo J; Barkun AN
    Am J Gastroenterol; 2001 May; 96(5):1435-40. PubMed ID: 11374679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of malignant biliary obstruction with polyurethane-covered Wallstents.
    Hausegger KA; Thurnher S; Bodendörfer G; Zollikofer CL; Uggowitzer M; Kugler C; Lammer J
    AJR Am J Roentgenol; 1998 Feb; 170(2):403-8. PubMed ID: 9456954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-expandable metallic stents for malignant biliary obstruction with an anomalous pancreaticobiliary junction.
    Kogure H; Tsujino T; Yagioka H; Sasaki T; Nakai Y; Hirano K; Sasahira N; Isayama H; Tada M; Kawabe T; Omata M
    Surg Endosc; 2008 Mar; 22(3):787-91. PubMed ID: 17704880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expandable metallic biliary stents.
    Chu KM; Lai EC
    Aust N Z J Surg; 1994 Dec; 64(12):836-9. PubMed ID: 7980257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unresectable malignant biliary obstruction: treatment by self-expandable biliary endoprostheses.
    Glättli A; Stain SC; Baer HU; Schweizer W; Triller J; Blumgart LH
    HPB Surg; 1993; 6(3):175-84. PubMed ID: 7683908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy of covered versus uncovered metallic stents in treating inoperable malignant common bile duct obstruction: a randomized trial.
    Lee SJ; Kim MD; Lee MS; Kim IJ; Park SI; Won JY; Lee DY
    J Vasc Interv Radiol; 2014 Dec; 25(12):1912-20. PubMed ID: 25085230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary and revision efficacy of cross-wired metallic stents for endoscopic bilateral stent-in-stent placement in malignant hilar biliary strictures.
    Lee TH; Moon JH; Kim JH; Park DH; Lee SS; Choi HJ; Cho YD; Park SH; Kim SJ
    Endoscopy; 2013; 45(2):106-13. PubMed ID: 23212727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant biliary obstruction: treatment with interventional radiology.
    Zhai R; Qian X; Dai D; Yu P
    Chin Med J (Engl); 2003 Jun; 116(6):888-92. PubMed ID: 12877801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for recurrent biliary obstruction following placement of self-expandable metallic stents in patients with malignant perihilar biliary stricture.
    Miura S; Kanno A; Masamune A; Hamada S; Hongou S; Yoshida N; Nakano E; Takikawa T; Kume K; Kikuta K; Hirota M; Yoshida H; Katayose Y; Unno M; Shimosegawa T
    Endoscopy; 2016 Jun; 48(6):536-45. PubMed ID: 26987646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small cell- versus large cell-sized metal stent in endoscopic bilateral stent-in-stent placement for malignant hilar biliary obstruction.
    Lee JM; Lee SH; Chung KH; Park JM; Paik WH; Woo SM; Lee WJ; Ryu JK; Kim YT
    Dig Endosc; 2015 Sep; 27(6):692-9. PubMed ID: 25708157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
    Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
    World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.